29 junio 2015
About 20 percent of follicular lymphoma patients consistently experience their disease coming back within two years of being treated with the latest therapies. New research confirms that patients in this group have very poor survival outcomes; 50 percent die in five years. People who relapse early may have a disease with distinctly different biology and should not be approached the same at diagnosis nor at the time of relapse in terms of therapies, scientists report.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/oTavHWjSx0I/150629180108.htm
